Work

Supplementary Data from Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4+ Th1 Responses and Potential Use as a Cancer Vaccine

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Data from Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4+ Th1 Responses and Potential Use as a Cancer Vaccine
Language: English
Subfield: Immunology
Open Access status: gold
OpenAlex ID: W4362548896
Cites:
Cited by:
Related to: 10